BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2898811)

  • 41. Release of a dynorphin A (1-8) degrading enzyme from the spinal cord by intraventricular morphine in the rat.
    Tseng LF
    Life Sci; 1988; 42(13):1287-93. PubMed ID: 2451104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spinal antinociceptive action of three representative opioid peptides in frogs.
    Stevens CW; Pezalla PD; Yaksh TL
    Brain Res; 1987 Jan; 402(1):201-3. PubMed ID: 2881600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of chronic treatment with morphine, midazolam and both together on dynorphin(1-13) levels in the rat.
    Rattan AK; Tejwani GA
    Brain Res; 1997 Apr; 754(1-2):239-44. PubMed ID: 9134981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tail-pinch method in vitro and the effects of some antinociceptive compounds.
    Yanagisawa M; Murakoshi T; Tamai S; Otsuka M
    Eur J Pharmacol; 1984 Nov; 106(2):231-9. PubMed ID: 6152216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrathecal dynorphin A1-13 and dynorphin A3-13 reduce rat spinal cord blood flow by non-opioid mechanisms.
    Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
    Brain Res; 1987 Dec; 436(2):374-9. PubMed ID: 2893653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analgesic activity of enkephalins following intracerebral administration in the rat.
    Malick JB; Goldstein JM
    Life Sci; 1977 Mar; 20(5):827-32. PubMed ID: 15714767
    [No Abstract]   [Full Text] [Related]  

  • 47. Sites of analgesic action of dynorphin.
    Kaneko T; Nakazawa T; Ikeda M; Yamatsu K; Iwama T; Wada T; Satoh M; Takagi H
    Life Sci; 1983; 33 Suppl 1():661-4. PubMed ID: 6141507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analgesic activity and release of [MET5]enkephalin-Arg6-Gly7-Leu8 from rat spinal cord in vivo.
    Iadarola MJ; Tang J; Costa E; Yang HY
    Eur J Pharmacol; 1986 Feb; 121(1):39-48. PubMed ID: 2420613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats.
    Przewłocki R; Shearman GT; Herz A
    Neuropeptides; 1983 Jan; 3(3):233-40. PubMed ID: 16229165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increase in met-enkephalin level and antinociceptive effects induced by kelatorphan in the rat spinal cord.
    Fournié-Zaluski MC; Bourgoin S; Cesselin F; Hamon M; Le Bars D; Dickenson AH; Roques BP
    NIDA Res Monogr; 1986; 75():454-6. PubMed ID: 3123963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Actions of opioids on primate spinothalamic tract neurons.
    Willcockson WS; Kim J; Shin HK; Chung JM; Willis WD
    J Neurosci; 1986 Sep; 6(9):2509-20. PubMed ID: 2875139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of opiate treatment on the postdecapitation reflex and monoamine metabolism in the rat spinal cord.
    Plaznik A; De Simoni MG; Algeri S
    Pharmacol Biochem Behav; 1983 Sep; 19(3):427-9. PubMed ID: 6634893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracerebroventricular morphine produces diuresis 24 h after previous dynorphin/morphine treatment.
    Hong O; Young GA; Khazan N
    Eur J Pharmacol; 1986 Dec; 132(1):83-5. PubMed ID: 2880730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynorphin blocks opioid inhibition of macrophage-colony stimulating factor-induced proliferation of bone marrow cells.
    Roy S; Loh HH; Lee NM
    Eur J Pharmacol; 1991 Sep; 202(3):355-9. PubMed ID: 1684159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential release of substance P and somatostatin in the rat spinal cord in response to noxious cold and heat: effect of dynorphin A(1-17).
    Tiseo PJ; Adler MW; Liu-Chen LY
    NIDA Res Monogr; 1989; 95():297. PubMed ID: 2484266
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effects of E2078, a new dynorphin derivative, on pituitary-adrenocortical functions in dogs].
    Muraoka M
    Masui; 1990 Jul; 39(7):900-9. PubMed ID: 1976831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on the effect of SCH-34826 and thiorphan on [Met5]enkephalin levels and release in rat spinal cord.
    Yaksh TL; Chipkin RE
    Eur J Pharmacol; 1989 Aug; 167(3):367-73. PubMed ID: 2806377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The partial opiate receptor agonists, dezocine and ciramadol act as mu receptor antagonists at the feline ileocecal sphincter.
    Ouyang A
    Life Sci; 1989; 45(16):1491-7. PubMed ID: 2572952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies of peptidergic input to the lateral spinal nucleus.
    Cliffer KD; Urca G; Elde RP; Giesler GJ
    Brain Res; 1988 Sep; 460(2):356-60. PubMed ID: 2465062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynorphin A-(1-13)-morphine interactions: quantitative and qualitative EEG properties differ in morphine-naive vs. morphine-tolerant rats.
    Meng Y; Young GA
    Brain Res Bull; 1994; 33(3):255-65. PubMed ID: 7904888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.